PT833944E - Ligandos de ácido nucleico que se ligam a, e inibem, adn-polimerases - Google Patents
Ligandos de ácido nucleico que se ligam a, e inibem, adn-polimerases Download PDFInfo
- Publication number
- PT833944E PT833944E PT96919197T PT96919197T PT833944E PT 833944 E PT833944 E PT 833944E PT 96919197 T PT96919197 T PT 96919197T PT 96919197 T PT96919197 T PT 96919197T PT 833944 E PT833944 E PT 833944E
- Authority
- PT
- Portugal
- Prior art keywords
- bind
- nucleic acid
- ligands
- dna polymerases
- acid ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/487,426 US5763173A (en) | 1990-06-11 | 1995-06-07 | Nucleic acid ligand inhibitors to DNA polymerases |
US08/484,557 US5693502A (en) | 1990-06-11 | 1995-06-07 | Nucleic acid ligand inhibitors to DNA polymerases |
US08/487,720 US5874557A (en) | 1990-06-11 | 1995-06-07 | Nucleic acid ligand inhibitors to DNA polymerases |
Publications (1)
Publication Number | Publication Date |
---|---|
PT833944E true PT833944E (pt) | 2009-04-14 |
Family
ID=27413687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96919197T PT833944E (pt) | 1995-06-07 | 1996-06-05 | Ligandos de ácido nucleico que se ligam a, e inibem, adn-polimerases |
Country Status (11)
Country | Link |
---|---|
US (1) | US6020130A (pt) |
EP (2) | EP0833944B1 (pt) |
JP (2) | JP4335975B2 (pt) |
AT (2) | ATE494394T1 (pt) |
AU (1) | AU726844B2 (pt) |
CA (1) | CA2223078C (pt) |
DE (2) | DE69638318D1 (pt) |
DK (2) | DK2080813T3 (pt) |
ES (1) | ES2321243T3 (pt) |
PT (1) | PT833944E (pt) |
WO (1) | WO1996041010A1 (pt) |
Families Citing this family (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060084797A1 (en) * | 1990-06-11 | 2006-04-20 | Gilead Sciences, Inc. | High affinity TGFbeta nucleic acid ligands and inhibitors |
US5475096A (en) * | 1990-06-11 | 1995-12-12 | University Research Corporation | Nucleic acid ligands |
US20040132067A1 (en) * | 1990-06-11 | 2004-07-08 | Somalogic, Inc. | Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
US6395888B1 (en) * | 1996-02-01 | 2002-05-28 | Gilead Sciences, Inc. | High affinity nucleic acid ligands of complement system proteins |
US6458539B1 (en) * | 1993-09-17 | 2002-10-01 | Somalogic, Inc. | Photoselection of nucleic acid ligands |
US6183967B1 (en) * | 1995-06-07 | 2001-02-06 | Nexstar Pharmaceuticals | Nucleic acid ligand inhibitors to DNA polymerases |
WO1998002582A2 (en) | 1996-07-16 | 1998-01-22 | Gen-Probe Incorporated | Methods for detecting and amplifying nucleic acid sequences using modified oligonucleotides having increased target specific t¿m? |
US7070925B1 (en) | 1996-07-16 | 2006-07-04 | Gen-Probe Incorporated | Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe |
US6426335B1 (en) * | 1997-10-17 | 2002-07-30 | Gilead Sciences, Inc. | Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
AU759915B2 (en) * | 1998-07-31 | 2003-05-01 | Gen-Probe Incorporated | Reversible inhibiting probes |
EP1002875A1 (en) * | 1998-11-17 | 2000-05-24 | Mira Diagnostica GmbH | An oligonucleotide inhibitor of thermostable polymerase |
AU5008900A (en) * | 1999-05-12 | 2000-11-21 | Invitrogen Corporation | Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
EP1178954A1 (en) * | 1999-05-12 | 2002-02-13 | President And Fellows Of Harvard College | A structure-based approach to design inhibitors of protein-processivity factor interactions |
US6830902B1 (en) | 1999-07-02 | 2004-12-14 | Invitrogen Corporation | Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
NZ516894A (en) * | 1999-07-02 | 2004-06-25 | Invitrogen Corp | Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
US6214557B1 (en) * | 2000-06-06 | 2001-04-10 | Washington University | Cold sensitive mutant DNA polymerases |
US8568766B2 (en) * | 2000-08-24 | 2013-10-29 | Gattadahalli M. Anantharamaiah | Peptides and peptide mimetics to treat pathologies associated with eye disease |
WO2002030465A2 (en) | 2000-10-12 | 2002-04-18 | University Of Rochester | Compositions that inhibit proliferation of cancer cells |
EP2070939B1 (en) | 2001-05-25 | 2014-04-02 | Duke University | Modulators of pharmacological agents |
US6667165B2 (en) * | 2001-11-13 | 2003-12-23 | Eppendorf Ag | Method and compositions for reversible inhibition of thermostable polymerases |
CN1856504B (zh) | 2002-02-06 | 2010-12-29 | 史戴西思技术有限公司 | 抗梗塞分子 |
WO2003093452A2 (en) * | 2002-02-26 | 2003-11-13 | University Of Utah Research Foundation | Variants of nedd4l associated with hypertension and viral budding |
US20040249130A1 (en) * | 2002-06-18 | 2004-12-09 | Martin Stanton | Aptamer-toxin molecules and methods for using same |
CA2487809A1 (en) * | 2002-06-18 | 2003-12-24 | Archemix Corp. | Aptamer-toxin molecules and methods for using same |
US20040110235A1 (en) * | 2002-07-25 | 2004-06-10 | David Epstein | Regulated aptamer therapeutics |
US20050287648A1 (en) | 2002-08-05 | 2005-12-29 | University Of Rochester | Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof |
US9303262B2 (en) * | 2002-09-17 | 2016-04-05 | Archemix Llc | Methods for identifying aptamer regulators |
US10100316B2 (en) * | 2002-11-21 | 2018-10-16 | Archemix Llc | Aptamers comprising CPG motifs |
AU2003294437A1 (en) * | 2002-11-21 | 2004-06-18 | Archemix Corporation | Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
US8853376B2 (en) | 2002-11-21 | 2014-10-07 | Archemix Llc | Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
US20050124565A1 (en) * | 2002-11-21 | 2005-06-09 | Diener John L. | Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
AU2003297682A1 (en) * | 2002-12-03 | 2004-06-23 | Archemix Corporation | Method for in vitro selection of 2'-substituted nucleic acids |
US20050037394A1 (en) * | 2002-12-03 | 2005-02-17 | Keefe Anthony D. | Method for in vitro selection of 2'-substituted nucleic acids |
EP1615942B1 (en) | 2003-04-01 | 2016-03-16 | Luminex Corporation | Polymerase inhibitor and method of using same |
US20050250106A1 (en) * | 2003-04-24 | 2005-11-10 | David Epstein | Gene knock-down by intracellular expression of aptamers |
WO2004094666A1 (en) * | 2003-04-24 | 2004-11-04 | Dzieglewska, Hanna | Allele-specific mutation detection assay |
US7727969B2 (en) * | 2003-06-06 | 2010-06-01 | Massachusetts Institute Of Technology | Controlled release nanoparticle having bound oligonucleotide for targeted delivery |
US20050112585A1 (en) * | 2003-11-21 | 2005-05-26 | Dominic Zichi | Method for adjusting the quantification range of individual analytes in a multiplexed assay |
US7803931B2 (en) | 2004-02-12 | 2010-09-28 | Archemix Corp. | Aptamer therapeutics useful in the treatment of complement-related disorders |
PT2860251T (pt) * | 2004-02-12 | 2018-06-07 | Archemix Llc | Terapêuticas com aptâmeros úteis no tratamento de desordens relacionadas com o complemento |
US20060193821A1 (en) * | 2004-03-05 | 2006-08-31 | Diener John L | Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
AU2005220910A1 (en) * | 2004-03-05 | 2005-09-22 | Archemix Corp. | Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
US20080214489A1 (en) * | 2004-04-19 | 2008-09-04 | Anthony Dominic Keefe | Aptamer-mediated intracellular delivery of oligonucleotides |
US7579450B2 (en) * | 2004-04-26 | 2009-08-25 | Archemix Corp. | Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics |
US7566701B2 (en) * | 2004-09-07 | 2009-07-28 | Archemix Corp. | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
JP2008512097A (ja) * | 2004-09-07 | 2008-04-24 | アーケミックス コーポレイション | アプタマー医薬品化学 |
CA2579374A1 (en) | 2004-09-07 | 2006-03-30 | Archemix Corp. | Aptamers to von willebrand factor and their use as thrombotic disease therapeutics |
US7517977B2 (en) * | 2004-10-18 | 2009-04-14 | Brandeis University | Reagents and methods for improving reproducibility and reducing mispriming in PCR amplification |
AU2006204006A1 (en) * | 2005-01-06 | 2006-07-13 | Applera Corporation | Polypeptides having nucleic acid binding activity and compositions and methods for nucleic acid amplification |
CN101218256B (zh) | 2005-03-23 | 2017-04-19 | 根马布股份公司 | 用于治疗多发性骨髓瘤的cd38抗体 |
US7476733B2 (en) * | 2005-03-25 | 2009-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease |
US20070059713A1 (en) | 2005-09-09 | 2007-03-15 | Lee Jun E | SSB-DNA polymerase fusion proteins |
WO2007041201A2 (en) | 2005-10-03 | 2007-04-12 | Applera Corporation | Compositions, methods, and kits for amplifying nucleic acids |
CA2625349A1 (en) * | 2005-10-06 | 2007-04-19 | Emthrax, Llc | Methods and compositions relating to anthrax spore glycoproteins as vaccines |
US8080534B2 (en) * | 2005-10-14 | 2011-12-20 | Phigenix, Inc | Targeting PAX2 for the treatment of breast cancer |
EP1934331A4 (en) | 2005-10-14 | 2009-01-21 | Musc Found For Res Dev | PAX2 AS A TARGET FOR THE INDUCTION OF DEFB1-MEDIATED TUMORIMMUNITY AND CANCER THERAPY |
WO2007096182A1 (en) * | 2006-02-27 | 2007-08-30 | Roche Diagnostics Gmbh | Pcr hot start by magnesium sequestration |
ES2562423T3 (es) * | 2006-03-08 | 2016-03-04 | Archemix Llc | Aptámeros de unión a complemento y agentes anti-C5 útiles para el tratamiento de trastornos oculares |
RU2394915C2 (ru) * | 2006-03-24 | 2010-07-20 | Александр Борисович Четверин | Бесконтактные способы обнаружения молекулярных колоний, наборы реагентов и устройство для их осуществления |
DE102006015960A1 (de) | 2006-04-04 | 2007-10-11 | Qiagen Gmbh | Gemisch reversibel inhibierter Enzyme |
US7786294B2 (en) * | 2006-06-08 | 2010-08-31 | Saint Louis University | Compositions and methods for amplification and cloning of near full-length viral genome samples |
CN106566855B (zh) * | 2006-07-31 | 2021-11-09 | 苏州新海生物科技股份有限公司 | 使用可逆修饰寡核苷酸扩增核酸 |
US9045522B2 (en) | 2006-07-31 | 2015-06-02 | Wanli Bi | Nucleic acid amplification using a reversibly modified oligonucleotide |
WO2008036406A2 (en) | 2006-09-21 | 2008-03-27 | University Of Rochester | Compositions and methods related to protein displacement therapy for myotonic distrophy |
EP2104516B1 (en) | 2006-11-01 | 2015-01-07 | University of Rochester | Methods and compositions related to the structure and function of apobec3g |
CA2672297A1 (en) | 2006-12-11 | 2008-06-19 | University Of Utah Research Foundation | Compositions and methods for treating pathologic angiogenesis and vascular permeability |
WO2008134077A1 (en) * | 2007-04-30 | 2008-11-06 | Archemix Corp. | Metabolic profile directed aptamer medicinal chemistry |
US20090203766A1 (en) * | 2007-06-01 | 2009-08-13 | Archemix Corp. | vWF aptamer formulations and methods for use |
EP2069496A4 (en) | 2007-07-17 | 2010-01-27 | Somalogic Inc | SELEX AND PHOTOSELEX ENHANCED |
CA2704729C (en) * | 2007-08-28 | 2020-06-23 | Uab Research Foundation | Synthetic apolipoprotein e mimicking polypeptides and methods of use |
EP2195340A4 (en) | 2007-08-28 | 2011-05-11 | Uab Research Foundation | SYNTHETIC APOLIPOPROTEIN E-IMITATING POLYPEPTIDES AND METHOD OF USE |
EP2268664B1 (en) * | 2007-12-03 | 2017-05-24 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Doc1 compositions and methods for treating cancer |
US20090233993A1 (en) * | 2008-03-06 | 2009-09-17 | Burnham Institute For Medical Research | Compositions and methods for inhibiting gsk3 activity and uses thereof |
CA2658520C (en) | 2008-03-19 | 2016-11-08 | F. Hoffmann-La Roche Ag | Nucleic acid amplification in the presence of modified randomers |
EP2853897A1 (en) | 2008-05-08 | 2015-04-01 | University Of Utah Research Foundation | Sensory receptors for chronic fatigue and pain and uses thereof |
CA2734322A1 (en) * | 2008-08-15 | 2010-02-18 | Georgetown University | Na channels, disease, and related assays and compositions |
US7910720B2 (en) | 2008-09-09 | 2011-03-22 | Roche Diagnostics Operations, Inc. | Polyanion for improved nucleic acid amplification |
US20120070443A1 (en) | 2008-12-02 | 2012-03-22 | University Of Utah Research Foundation | Pde1 as a target therapeutic in heart disease |
WO2010065924A1 (en) * | 2008-12-05 | 2010-06-10 | Dna Polymerase Technology Inc. | Compositions for improving gene amplification |
WO2010105074A1 (en) | 2009-03-12 | 2010-09-16 | Brandeis University | Reagents and methods for pcr |
WO2011031974A1 (en) | 2009-09-10 | 2011-03-17 | Southern Research Institute | Acridine analogs in the treatment of gliomas |
US8841429B2 (en) * | 2009-11-03 | 2014-09-23 | Vivonics, Inc. | Nucleic acid ligands against infectious prions |
US8236570B2 (en) | 2009-11-03 | 2012-08-07 | Infoscitex | Methods for identifying nucleic acid ligands |
US20110207789A1 (en) | 2010-02-19 | 2011-08-25 | Ye Fang | Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents |
US20110250598A1 (en) | 2010-04-12 | 2011-10-13 | Ulrike Fischer | Detergent free polymerases |
US10301674B2 (en) * | 2010-08-20 | 2019-05-28 | Life Technologies Corporation | Polymerase assay with a FRET substrate |
JP2014515012A (ja) | 2011-03-15 | 2014-06-26 | ユニヴァーシティー オブ ユタ リサーチ ファウンデーション | 血管関連黄斑症およびその症状の診断および治療方法 |
JP5830286B2 (ja) * | 2011-07-12 | 2015-12-09 | アークレイ株式会社 | 核酸の増幅検出方法およびキット |
JP5977000B2 (ja) * | 2011-07-12 | 2016-08-24 | アークレイ株式会社 | 核酸の増幅検出方法およびキット |
EP2769219B1 (en) | 2011-10-21 | 2017-08-30 | Decimadx LLC | Point-of care immunoassay for quantitative small analyte detection |
DK2855692T3 (da) | 2012-05-24 | 2019-10-14 | Univ Utah Res Found | Ekstrem pcr |
KR102264617B1 (ko) | 2012-06-14 | 2021-06-14 | 라이프 테크놀로지스 코포레이션 | 폴리머라제 연쇄 반응 (pcr)을 위한 신규 조성물, 방법 및 키트 |
US9212392B2 (en) | 2012-09-25 | 2015-12-15 | Exact Sciences Corporation | Normalization of polymerase activity |
KR102384693B1 (ko) | 2013-03-12 | 2022-04-07 | 유니버시티 오브 유타 리서치 파운데이션 | 세포사멸 유도용 조성물 및 방법 |
CN103966184A (zh) * | 2014-05-06 | 2014-08-06 | 江西省科学院微生物研究所 | 一种实时热启动Taq酶及其制备方法 |
US10653747B2 (en) | 2014-07-31 | 2020-05-19 | Uab Research Foundation | ApoE mimetic peptides and higher potency to clear plasma cholesterol |
CA3000824C (en) | 2015-11-05 | 2024-02-13 | University Of Utah Research Foundation | Extreme reverse transcription pcr |
WO2017176894A1 (en) | 2016-04-06 | 2017-10-12 | Ohio State Innovation Foundation | Rna ligand-displaying exosomes for specific delivery of therapeutics to cell by rna nanotechnology |
EP3471740A4 (en) | 2016-06-15 | 2020-03-04 | University of Utah Research Foundation | COMPOSITIONS AND METHODS OF USING ALBUMIN-BASED NANOMEDICINES |
KR20190037273A (ko) | 2016-08-03 | 2019-04-05 | 에이치 리 모피트 캔서 센터 앤드 리서어치 인스티튜트 아이엔씨 | Tlr9 표적 치료제 |
WO2019046288A1 (en) | 2017-08-31 | 2019-03-07 | Massachusetts Institute Of Technology | MULTIPLEX COMPOSITIONS AND ASSAYS FOR CHARACTERIZING ACTIVE PROTEASE AND THEIR INHIBITORS |
WO2019051355A1 (en) | 2017-09-08 | 2019-03-14 | Ohio State Innovation Foundation | NEW MICROARN INHIBITOR THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS |
WO2019071150A1 (en) | 2017-10-06 | 2019-04-11 | University Of Utah Research Foundation | FUSION PROTEIN FOR TARGETED THERAPY OF AUTOIMMUNE DISEASE |
CN107619430B (zh) * | 2017-10-17 | 2021-01-15 | 江西省科学院微生物研究所 | 一种热稳定的Taq酶温控亲和性配体及其制备方法、应用 |
GB201812192D0 (en) | 2018-07-26 | 2018-09-12 | Ttp Plc | Variable temperature reactor, heater and control circuit for the same |
WO2020058967A1 (en) | 2018-09-21 | 2020-03-26 | King Abdullah University Of Science And Technology | Ligand detection by aptamers with a built-in reporter |
JP2023531027A (ja) | 2020-06-22 | 2023-07-20 | ▲蘇▼州新海生物科技股▲ふん▼有限公司 | 核酸リガンド、およびその使用 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS562226A (en) | 1979-06-13 | 1981-01-10 | Nissan Motor Co Ltd | Dozing drive detector |
DE229046T1 (de) * | 1985-03-30 | 1987-12-17 | Marc Genf/Geneve Ballivet | Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren. |
US5354657A (en) * | 1988-01-12 | 1994-10-11 | Boehringer Mannheim Gmbh | Process for the highly specific detection of nucleic acids in solid |
WO1989006694A1 (en) * | 1988-01-15 | 1989-07-27 | Trustees Of The University Of Pennsylvania | Process for selection of proteinaceous substances which mimic growth-inducing molecules |
US5348010A (en) | 1989-02-24 | 1994-09-20 | Medrea, Inc., Pennsylvania Corp., Pa. | Intracavity probe and interface device for MRI imaging and spectroscopy |
US5476766A (en) * | 1990-06-11 | 1995-12-19 | Nexstar Pharmaceuticals, Inc. | Ligands of thrombin |
US5475096A (en) | 1990-06-11 | 1995-12-12 | University Research Corporation | Nucleic acid ligands |
US5637459A (en) | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
US5527894A (en) * | 1990-06-11 | 1996-06-18 | Nexstar Pharmacueticals, Inc. | Ligands of HIV-1 tat protein |
US5683867A (en) | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
US5587468A (en) * | 1990-06-11 | 1996-12-24 | University Research Corporation | High affinity nucleic acid ligands to HIV integrase |
US5567588A (en) * | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
US5503978A (en) * | 1990-06-11 | 1996-04-02 | University Research Corporation | Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase |
US5705337A (en) | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
US5459015A (en) * | 1990-06-11 | 1995-10-17 | Nexstar Pharmaceuticals, Inc. | High-affinity RNA ligands of basic fibroblast growth factor |
US5580737A (en) * | 1990-06-11 | 1996-12-03 | Nexstar Pharmaceuticals, Inc. | High-affinity nucleic acid ligands that discriminate between theophylline and caffeine |
US5472841A (en) * | 1990-06-11 | 1995-12-05 | Nexstar Pharmaceuticals, Inc. | Methods for identifying nucleic acid ligands of human neutrophil elastase |
US5496938A (en) * | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
US5543293A (en) * | 1990-06-11 | 1996-08-06 | Nexstar Pharmaceuticals, Inc. | DNA ligands of thrombin |
JPH06508022A (ja) * | 1991-02-21 | 1994-09-14 | ギリアド サイエンシズ,インコーポレイテッド | 生体分子に特異的なアプタマーおよび生産方法 |
US5338671A (en) * | 1992-10-07 | 1994-08-16 | Eastman Kodak Company | DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody |
US5567604A (en) * | 1993-04-23 | 1996-10-22 | Aronex Pharmaceuticals, Inc. | Anti-viral guanosine-rich oligonucleotides |
US20170110787A1 (en) | 2015-10-14 | 2017-04-20 | Apple Inc. | Electronic Devices With Millimeter Wave Antennas And Metal Housings |
-
1996
- 1996-06-05 DE DE69638318T patent/DE69638318D1/de not_active Expired - Lifetime
- 1996-06-05 AT AT09000032T patent/ATE494394T1/de active
- 1996-06-05 DK DK09000032.4T patent/DK2080813T3/da active
- 1996-06-05 PT PT96919197T patent/PT833944E/pt unknown
- 1996-06-05 JP JP50176797A patent/JP4335975B2/ja not_active Expired - Lifetime
- 1996-06-05 DK DK96919197T patent/DK0833944T3/da active
- 1996-06-05 WO PCT/US1996/009451 patent/WO1996041010A1/en active Application Filing
- 1996-06-05 DE DE69637805T patent/DE69637805D1/de not_active Expired - Lifetime
- 1996-06-05 US US08/945,734 patent/US6020130A/en not_active Expired - Fee Related
- 1996-06-05 EP EP96919197A patent/EP0833944B1/en not_active Expired - Lifetime
- 1996-06-05 AU AU61598/96A patent/AU726844B2/en not_active Expired
- 1996-06-05 ES ES96919197T patent/ES2321243T3/es not_active Expired - Lifetime
- 1996-06-05 CA CA002223078A patent/CA2223078C/en not_active Expired - Lifetime
- 1996-06-05 EP EP09000032A patent/EP2080813B1/en not_active Expired - Lifetime
- 1996-06-05 AT AT96919197T patent/ATE420202T1/de active
-
2008
- 2008-09-10 JP JP2008263257A patent/JP2009106277A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2321243T3 (es) | 2009-06-03 |
DE69637805D1 (de) | 2009-02-26 |
EP2080813B1 (en) | 2011-01-05 |
EP0833944B1 (en) | 2009-01-07 |
DE69638318D1 (de) | 2011-02-17 |
ATE420202T1 (de) | 2009-01-15 |
CA2223078C (en) | 2008-11-25 |
AU726844B2 (en) | 2000-11-23 |
JP2009106277A (ja) | 2009-05-21 |
AU6159896A (en) | 1996-12-30 |
EP0833944A1 (en) | 1998-04-08 |
ATE494394T1 (de) | 2011-01-15 |
US6020130A (en) | 2000-02-01 |
CA2223078A1 (en) | 1996-12-19 |
EP2080813A1 (en) | 2009-07-22 |
DK2080813T3 (da) | 2011-03-28 |
DK0833944T3 (da) | 2009-05-11 |
WO1996041010A1 (en) | 1996-12-19 |
JPH11507223A (ja) | 1999-06-29 |
JP4335975B2 (ja) | 2009-09-30 |
EP0833944A4 (en) | 1999-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT833944E (pt) | Ligandos de ácido nucleico que se ligam a, e inibem, adn-polimerases | |
HK1044803A1 (en) | Nucleic acid ligand inhibitors to dna polymerases | |
EP0669401A3 (en) | Amplification of long nucleic acid sequences with PCR. | |
CA2254111A1 (en) | Artificial mismatch hybridization | |
CA2056983A1 (en) | Process for nucleic acid hybridization and amplification | |
IL123694A0 (en) | Modified primers | |
WO2003020739A3 (en) | Novel lna compositions and uses thereof | |
GB9901475D0 (en) | A method of DNA sequencing | |
EP0663447A3 (en) | Method of detecting a specific polynucleotide | |
DE69626111D1 (de) | Universale primersequenz zur multiplex dna amplifikation | |
DE60112746D1 (de) | Kälteempfindliche dna-polymerasemutanten | |
EP0258017A3 (en) | Purified thermostable enzyme and process for amplifying, detecting, and/or cloning nucleic acid sequences using said enzyme | |
ATE427361T1 (de) | Verfahren zur dna-amplifikation und - sequenzierung | |
WO2004022770A3 (en) | Compositions and methods for synthesizing nucleic acids | |
WO1995014782A3 (en) | A modified thermo resistant dna polymerase | |
WO1996006949A3 (en) | Nucleic acid hybridization assay probes targeted to mycoplasma pneumoniae nucleic acid | |
EP1607480A3 (en) | Method for synthesizing DNA | |
WO2001009347A3 (en) | Archaeal replication accessory factors and methods of use | |
EP0872561A3 (en) | Neisseria gonorrhoae-specific oligonucleotides | |
Stemmer | Enzymatic inverse polymerase chain reaction | |
Chenchik et al. | Method for suppressing dna fragment amplification during pcr | |
WO2002050094A3 (en) | Nucleic acid synthesis by primer extension on successive templates |